Mantle Cell Lymphoma (MCL) Recruiting Phase 1 Trials for Lenalidomide (DB00480)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03523975Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell LymphomaTreatment
NCT02446236Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell LymphomaTreatment